Vascepa
Amarin gets FDA panel okay for new Vascepa indication
Phil Taylor
Amarin, cardiovascular disease, fda, Vascepa
0 Comment
X
Amarin gets FDA panel okay for new Vascepa indication
https://pharmaphorum.com/news/amarin-gets-fda-panel-okay-for-new-vascepa-indication/
X
Amarin’s Vascepa gets priority review for cardiovascular label expansion
https://pharmaphorum.com/news/amarins-vascepa-gets-priority-review-for-cardiovascular-label-expansion/